Hospital admission in community-acquired pneumonia;Decisión de ingreso hospitalario en la neumonía adquirida en la comunidad

Medicina Clinica

Volumn 131, Issue 6, 2008, Pages 216-217

  Torres, Antoni ^a   Menéndez, Rosario ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

COMMUNITY ACQUIRED PNEUMONIA; CONFUSION; EDITORIAL; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; URINARY FREQUENCY;

EID: 47749095960     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13124611     Document Type: Editorial

References (10)

1. Almirall J, Bolibar I, Vidal J, Sauca G, Coll P, Niklasson B, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J. 2000;15:757-63.
2. Fine MJ, Auble TE, Yealy DM, Hannsa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-50.
3. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001;56:296-301.
4. Capelastegui A, España PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006;27:151-7.
5. Niederman MS, Feldman C, Richards GA. Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds. Eur Respir J. 2006;27:9-11.
6. García-Vázquez E, Soto S, Gómez J, Herrero JA. Simple criteria to assess mortality in patients costh community-acquired pneumonia (CAP). Med Clin (Barc). 2008;131:201-4.
7. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44 Suppl 2:S27-72.
8. Alfageme I, Aspa J, Bello S, Blanquer J, Blanquer R, Borderias L, et al; Grupo de Estudio de la Neumonia Adquirida en la Comunidad. Area de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR. Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2005;41:272-89.
9. Menéndez R, Cavalcanti M, Reyes S, Mensa J, Martínez R, Marcos MA, et al. Markers of treatment failure in hospitalized community-acquired pneumonia. Thorax. 2008; 63:447-52.
10. Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med. 2006;174:84-93.